184 related articles for article (PubMed ID: 27718288)
1. Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.
Ando H; Miyamoto T; Kashima H; Takatsu A; Ishii K; Fujinaga Y; Shiozawa T
J Obstet Gynaecol Res; 2016 Nov; 42(11):1588-1598. PubMed ID: 27718288
[TBL] [Abstract][Full Text] [Related]
2. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
Takatsu A; Shiozawa T; Miyamoto T; Kurosawa K; Kashima H; Yamada T; Kaku T; Mikami Y; Kiyokawa T; Tsuda H; Ishii K; Togashi K; Koyama T; Fujinaga Y; Kadoya M; Hashi A; Susumu N; Konishi I
Int J Gynecol Cancer; 2011 Oct; 21(7):1287-96. PubMed ID: 21685796
[TBL] [Abstract][Full Text] [Related]
3. Biology and management of lobular endocervical glandular hyperplasia.
Miyamoto T; Kobara H; Shiozawa T
J Obstet Gynaecol Res; 2022 Dec; 48(12):3056-3067. PubMed ID: 36177810
[TBL] [Abstract][Full Text] [Related]
4. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
5. Two cases of adenocarcinoma in situ arising in lobular endocervical glandular hyperplasia indicating localization of mucin on the cluster surface as an early cytological finding of malignant transformation.
Okuyama R; Hashimoto H; Miura T; Sugita M; Arai M; Tsunoda H; Sasajima Y; Horiuchi H
Diagn Cytopathol; 2017 Sep; 45(9):842-847. PubMed ID: 28449203
[TBL] [Abstract][Full Text] [Related]
6. Limited frequency of malignant change in lobular endocervical glandular hyperplasia.
Kobara H; Miyamoto T; Ando H; Asaka R; Takatsu A; Ohya A; Asaka S; Shiozawa T
Int J Gynecol Cancer; 2020 Oct; 30(10):1480-1487. PubMed ID: 32883699
[TBL] [Abstract][Full Text] [Related]
7. Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).
Takatsu A; Miyamoto T; Fuseya C; Suzuki A; Kashima H; Horiuchi A; Ishii K; Shiozawa T
Virchows Arch; 2013 Jun; 462(6):645-51. PubMed ID: 23645358
[TBL] [Abstract][Full Text] [Related]
8. Case of minimal deviation adenocarcinoma: possible clinical link to lobular endocervical glandular hyperplasia as its origin.
Sugihara T; Nakagawa S; Sasajima Y; Matsumoto Y; Takeshita S; Ayabe T
J Obstet Gynaecol Res; 2015 Mar; 41(3):483-7. PubMed ID: 25257165
[TBL] [Abstract][Full Text] [Related]
9. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
[TBL] [Abstract][Full Text] [Related]
10. Successful pregnancy in a Peutz-Jeghers syndrome patient with lobular endocervical glandular hyperplasia.
Takei Y; Fujiwara H; Nagashima T; Takahashi Y; Takahashi S; Suzuki M
J Obstet Gynaecol Res; 2015 Mar; 41(3):468-73. PubMed ID: 25257303
[TBL] [Abstract][Full Text] [Related]
11. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
[TBL] [Abstract][Full Text] [Related]
12. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
[TBL] [Abstract][Full Text] [Related]
13. Characteristic Cytological Findings of Lobular Endocervical Glandular Hyperplasia Associated with Adenocarcinoma of the Uterine Cervix.
Ishii S; Ito T; Yamada M; Yamazaki N; Ikebata K; Fujiyama J; Furuta N; Komatsu K; Takeuchi K; Sugiyama Y; Takazawa Y
Acta Cytol; 2020; 64(6):556-562. PubMed ID: 32814324
[TBL] [Abstract][Full Text] [Related]
14. Uterine cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia: Radiologic-pathologic correlation.
Ohya A; Asaka S; Fujinaga Y; Kadoya M
J Obstet Gynaecol Res; 2018 Feb; 44(2):312-322. PubMed ID: 29144012
[TBL] [Abstract][Full Text] [Related]
15. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
[TBL] [Abstract][Full Text] [Related]
16. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
18. Utility of imaging modalities for predicting carcinogenesis in lobular endocervical glandular hyperplasia.
Omori M; Kondo T; Tagaya H; Watanabe Y; Fukasawa H; Kawai M; Nakazawa K; Hashi A; Hirata S
PLoS One; 2019; 14(8):e0221088. PubMed ID: 31415639
[TBL] [Abstract][Full Text] [Related]
19. Novel Strategy for the Management of Cervical Multicystic Diseases.
Yoshino A; Kobayashi E; Tsuboyama T; Fukui H; Tomiyama N; Sato K; Morii E; Nakatani E; Komura N; Sawada I; Tanaka Y; Hori K; Yoshimura A; Takahashi R; Iwamiya T; Hisa T; Nishimura S; Kitai T; Yokota H; Shindo M; Miyata H; Hashimoto N; Sakiyama K; Abe H; Ueda Y; Kimura T
Ann Surg Oncol; 2023 May; 30(5):2964-2973. PubMed ID: 36920588
[TBL] [Abstract][Full Text] [Related]
20. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
